Mechanisms Underlying Metastatic Pancreatic Cancer

被引:6
作者
Pitarresi, Jason R. [1 ,2 ]
Rustgi, Anil K. [3 ]
机构
[1] Univ Penn, Dept Med, Div Gastroenterol, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Abramson Canc Ctr, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Columbia Univ, Irving Med Ctr, Herbert Irving Comprehens Canc Ctr, New York, NY 10027 USA
来源
HUMAN CELL TRANSFORMATION: ADVANCES IN CELL MODELS FOR THE STUDY OF CANCER AND AGING | 2019年 / 1164卷
关键词
Pancreatic cancer; Epithelial-mesenchymal transition (EMT); Cellular plasticity; Metastasis; Metastatic organotropism; TO-MESENCHYMAL TRANSITION; DUCTAL ADENOCARCINOMA; EPITHELIAL PLASTICITY; CELLS; EMT; PROGRESSION; EXPRESSION; KRAS(G12D); INHIBITOR; COOPERATE;
D O I
10.1007/978-3-030-22254-3_1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Pancreatic ductal adenocarcinoma is an overwhelming fatal disease that often presents with overt metastases and ultimately causes the majority of cancer-associated deaths. The mechanisms underlying the metastatic cascade are complex, and research in recent years has begun to provide insights into the underlying drivers of this phenomenon. It has become clear that cancer cells, in particular pancreatic cancer cells, possess properties of plasticity involving bidirectional transition between epithelial and mesenchymal identities. Furthermore, recent work has begun to establish that there are distinct hybrid states between purely epithelial and purely mesenchymal states that cancer cells may reside, in order to thrive at different stages of carcinogenesis. We discuss how this plasticity is important for different phases of the metastatic cascade, from delamination to colonization, and how different epithelial-mesenchymal states may affect metastatic organotropism. In this review, we summarize the current understanding of pancreatic cancer cell plasticity and metastasis, and highlight current model systems that can be used to study these phenomena.
引用
收藏
页码:3 / 10
页数:8
相关论文
共 54 条
[21]   Tumour exosome integrins determine organotropic metastasis [J].
Hoshino, Ayuko ;
Costa-Silva, Bruno ;
Shen, Tang-Long ;
Rodrigues, Goncalo ;
Hashimoto, Ayako ;
Mark, Milica Tesic ;
Molina, Henrik ;
Kohsaka, Shinji ;
Di Giannatale, Angela ;
Ceder, Sophia ;
Singh, Swarnima ;
Williams, Caitlin ;
Soplop, Nadine ;
Uryu, Kunihiro ;
Pharmer, Lindsay ;
King, Tari ;
Bojmar, Linda ;
Davies, Alexander E. ;
Ararso, Yonathan ;
Zhang, Tuo ;
Zhang, Haiying ;
Hernandez, Jonathan ;
Weiss, Joshua M. ;
Dumont-Cole, Vanessa D. ;
Kramer, Kimberly ;
Wexler, Leonard H. ;
Narendran, Aru ;
Schwartz, Gary K. ;
Healey, John H. ;
Sandstrom, Per ;
Labori, Knut Jorgen ;
Kure, Elin H. ;
Grandgenett, Paul M. ;
Hollingsworth, Michael A. ;
de Sousa, Maria ;
Kaur, Sukhwinder ;
Jain, Maneesh ;
Mallya, Kavita ;
Batra, Surinder K. ;
Jarnagin, William R. ;
Brady, Mary S. ;
Fodstad, Oystein ;
Muller, Volkmar ;
Pantel, Klaus ;
Minn, Andy J. ;
Bissell, Mina J. ;
Garcia, Benjamin A. ;
Kang, Yibin ;
Rajasekhar, Vinagolu K. ;
Ghajar, Cyrus M. .
NATURE, 2015, 527 (7578) :329-+
[22]   Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-β signaling in cooperation with active Kras expression [J].
Ijichi, Hideaki ;
Chytil, Anna ;
Gorska, Agnieszka E. ;
Aakre, Mary E. ;
Fujitani, Yoshio ;
Fujitani, Shuko ;
Wright, Christopher V. E. ;
Moses, Harold L. .
GENES & DEVELOPMENT, 2006, 20 (22) :3147-3160
[23]   KrasG12D and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas [J].
Izeradjene, Kamel ;
Combs, Chelsea ;
Best, Melissa ;
Gopinathan, Aarthi ;
Wagner, Amary ;
Girady, William M. ;
Deng, Chu-Xia ;
Hruban, Ralph H. ;
Adsay, N. Volkan ;
Tuveson, David A. ;
Hingorani, Sunil R. .
CANCER CELL, 2007, 11 (03) :229-243
[24]   Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells [J].
Li, Yiwei ;
VandenBoom, Timothy G., II ;
Kong, Dejuan ;
Wang, Zhiwei ;
Ali, Shadan ;
Philip, Philip A. ;
Sarkar, Fazlul H. .
CANCER RESEARCH, 2009, 69 (16) :6704-6712
[25]   QUANTITATIVE RELATIONSHIP BETWEEN VOLUME OF TUMOR-CELL UNITS AND THEIR INTRA-VASCULAR SURVIVAL [J].
LIONE, A ;
BOSMANN, HB .
BRITISH JOURNAL OF CANCER, 1978, 37 (02) :248-253
[26]  
LIOTTA LA, 1974, CANCER RES, V34, P997
[27]  
LIOTTA LA, 1976, CANCER RES, V36, P889
[28]  
Ma C, 2015, MINERVA MED, V106, P193
[29]  
Ma JM, 2013, FUTURE ONCOL, V9, P917, DOI [10.2217/fon.13.76, 10.2217/FON.13.76]
[30]   ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat [J].
Meidhof, Simone ;
Brabletz, Simone ;
Lehmann, Waltraut ;
Preca, Bogdan-Tiberius ;
Mock, Kerstin ;
Ruh, Manuel ;
Schueler, Julia ;
Berthold, Maria ;
Weber, Anika ;
Burk, Ulrike ;
Luebbert, Michael ;
Puhr, Martin ;
Culig, Zoran ;
Wellner, Ulrich ;
Keck, Tobias ;
Bronsert, Peter ;
Kuesters, Simon ;
Hopt, Ulrich T. ;
Stemmler, Marc P. ;
Brabletz, Thomas .
EMBO MOLECULAR MEDICINE, 2015, 7 (06) :831-847